Resource
Christos Kyriakopoulos
Affiliation with the U.T.A.H. Cardiac Transplant Program
Last known relationship
Affiliation with the U.T.A.H. Cardiac Transplant Program
Last known relationship
Christos Kyriakopoulos is a cardiovascular physician whose research focuses on myocardial recovery, mechanical circulatory support, cardiogenic shock, and heart failure. He is currently listed by Duke Department of Medicine as a Fellow and House Staff member in the Cardiovascular Disease Fellowship. His recent publications examine individualized prediction of recovery during LVAD support, kidney function and recovery after LVAD support, native-heart survival in myocardial infarction-related cardiogenic shock, myocardial metabolism, sphingolipids, and potential anti-fibrotic therapies. Before joining Duke Heart, he described a seven-year affiliation with University of Utah Health and CVRTI. A 2022 ISHLT conference recap identified him with the Utah Cardiac Transplant Program and summarized his presentation on a clinical score for structural and functional cardiac improvement during mechanical circulatory support.
Publication: Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure
Publication: Association of Kidney Function With Myocardial Recovery and Adverse Events Following Left Ventricular Assist Device Circulatory Support
Publication: Beyond the Baseline Creatinine: A Comparison of Dynamic Versus Static Renal Function Metrics and Their Association with Mortality in Cardiogenic Shock
Publication: CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress That Enables Rescue by Gene Transfer
Publication: Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator
Publication: Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock
Publication: Integrative Clinical–Molecular Modeling Identifies LRRN4CL as a Determinant of Structural and Functional Myocardial Improvement
Publication: Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers: A Million Veteran Program Analysis
Publication: The Effect of Vericiguat on Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Pilot Randomized Study
Publication: The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support
Training includes Seven-year affiliation with University of Utah Health and CVRTI, House Staff at Duke, MD degree, and Cardiovascular Disease Fellowship, plus 2 more records.
Explore education and training